Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization: Two-year Outcomes from the Randomized BIOFLOW V Trial

被引:0
|
作者
Kandzari, David [1 ]
Koolen, Jacques J. [2 ]
Doros, Gheorghe [3 ]
Massaro, Joseph [4 ]
Garcia-Garcia, Hector [5 ]
Bennett, Johan [6 ]
Roguin, Ariel [7 ]
Gharib, Elie [8 ]
Cutlip, Donald [9 ]
Waksman, Ron [5 ]
机构
[1] Piedmont Heart Inst, Atlanta, GA USA
[2] Catharina Hosp, Eindhoven, Netherlands
[3] Baim Inst Clin Res, Boston, MA USA
[4] Boston Univ, Sch Publ Hlth, Boston, MA USA
[5] MedStar Washington Hosp Ctr, Washington, DC USA
[6] Univ Hosp Leuven, Leuven, Belgium
[7] RAMBAM, Haifa, Israel
[8] Charleston Area Med Ctr, Charleston, WV USA
[9] Baim Inst Clin Res, Beth Israel Deaconess Med Ctr, Boston, MA USA
关键词
D O I
10.1016/j.jacc.2018.08.1313
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TCT-195
引用
收藏
页码:B83 / B83
页数:1
相关论文
共 50 条
  • [1] Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable -Polymer Everolimus-Eluting Stents for Coronary Revascularization 3-Year Outcomes From the Randomized BIOFLOW V Trial
    Kandzari, David E.
    Koolen, Jacques J.
    Doros, Gheorghe
    Garcia-Garcia, Hector M.
    Bennett, Johan
    Roguin, Ariel
    Gharib, Elie G.
    Cutlip, Donald E.
    Waksman, Ron
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (11) : 1343 - 1353
  • [2] Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial
    Kandzari, David E.
    Mauri, Laura
    Koolen, Jacques J.
    Massaro, Joseph M.
    Doros, Gheorghe
    Garcia-Garcia, Hector M.
    Bennett, Johan
    Roguin, Ariel
    Gharib, Elie G.
    Cutlip, Donald E.
    Waksman, Ron
    [J]. LANCET, 2017, 390 (10105): : 1843 - 1852
  • [3] Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization: Three-Year Outcomes From the Randomized BIOFLOW V Trial
    Kandzari, David E.
    Koolen, Jacques J.
    Doros, Gheorghe
    Garcia-Garcia, Hector M.
    Bennett, Johan
    Roguin, Ariel
    Gharib, Elie G.
    Cutlip, Donald E.
    Waksman, Ron
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (04) : S42 - S42
  • [4] Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents
    Kandzari, David E.
    Koolen, Jacques J.
    Doros, Gheorghe
    Massaro, Joseph J.
    Garcia-Garcia, Hector M.
    Bennett, Johan
    Roguin, Ariel
    Gharib, Elie G.
    Cutlip, Donald E.
    Waksman, Ron
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (25) : 3287 - 3297
  • [5] Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents
    Kandzari, David E.
    Koolen, Jacques J.
    Doros, Gheorghe
    Garcia-Garcia, Hector M.
    Bennett, Johan
    Roguin, Ariel
    Gharib, Elie G.
    Cutlip, Donald E.
    Waksman, Ron
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (18) : 1852 - 1860
  • [6] Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis.
    Roguin, Ariel
    Kandzari, David
    Marcusohn, Erez
    Koolen, Jacques J.
    Doros, Gheorghe
    Massaro, Joseph
    Garcia-Garcia, Hector
    Bennett, Johan
    Gharib, Elie
    Cutlip, Donald
    Waksman, Ron
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B39 - B40
  • [7] Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): 3-Year Results of the Acute Coronary Syndrome Subgroup Analysis
    Kandzari, David
    Doros, Gheorghe
    Garcia-Garcia, Hector
    Bennett, Johan
    Gharib, Elie
    Waksman, Ron
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (17) : B17 - B18
  • [8] Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial (vol 390, pg 1843, 2017)
    Kandzari, D. E.
    Mauri, L.
    Koolen, J. J.
    [J]. LANCET, 2017, 390 (10105): : 1832 - 1832
  • [9] BIOFLOW V: COMPARISON OF ULTRATHIN SIROLIMUS-ELUTING BIORESORBABLE POLYMER STENTS WITH THIN EVEROLIMUS-ELUTING DURABLE POLYMER STENTS - TARGET VESSEL MYOCARDIAL INFARCTION ANALYSIS
    Kandzari, David E.
    Mauri, Laura
    Koolen, Jacques
    Massaro, Joseph
    Doros, Gheorghe
    Garcia, Hector Garcia
    Cutlip, Donald
    Waksman, Ron
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1017 - 1017
  • [10] Efficacy and Safety of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin, Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization of Patients With Diabetes Mellitus
    Waksman, Ron
    Shlofmitz, Evan
    Windecker, Stephan
    Koolen, Jacques J.
    Saito, Shigeru
    Kandzari, David
    Kolm, Paul
    Lipinski, Michael J.
    Torguson, Rebecca
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 (07): : 1020 - 1026